Global Stroke Therapeutics Market Share

Statistics for the 2023 & 2024 Global Stroke Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Global Stroke Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Stroke Therapeutics Industry

The stroke therapeutics market is fragmented, competitive, and consists of several major players. Patent expiry of major drugs is responsible for the entry of several generic drugs into the market, and thereby competition in the market increases. AstraZeneca, Amgen Inc., Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Merck and Co. Inc., Johnson and Johnson Inc., Pfizer Inc., Sanofi SA, Daiichi Sankyo Company, Limited, and Biogen Inc. are some of the key operating players in the stroke therapeutics market.

Stroke Therapeutics Market Leaders

  1. Bristol-Myers Squibb Company

  2. Boehringer Ingelheim International GmbH

  3. F. Hoffmann La Roche Ltd.

  4. Johnson & Johnson

  5. Pfizer Inc

*Disclaimer: Major Players sorted in no particular order

Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, F. Hoffmann La Roche Ltd., Johnson & Johnson, Pfizer Inc

Stroke Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)